Clinical trial
Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic…
NCT00305383 · Bausch Health Americas, Inc., Industry · Terminated
Key facts
| NCT number | NCT00305383 |
|---|---|
| Title | Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C |
| Official title | Analysis of Hepatitis C Viral Kinetics and Viramidine Pharmacokinetics Utilizing Two Treatment Regimens in Therapy-Naive Patients With Chronic Hepatitis C |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Drug |
| Interventions | Viramidine, Peginterferon alfa-2b |
| Enrollment | 100 |
| Start date | Nov 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Mar 21, 2006 |
| Last update posted | Jun 22, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: